Recruiting PHASE1 Malocclusion of Anterior Teeth

New treatment option for Malocclusion of Anterior Teeth

Official title Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial

ClinicalTrials.gov ID: NCT07479290

What this study is testing

What it's testing
Orthodontic treatment (OT) is characterized as a lengthy procedure and enormous effort has been harnessed to shorten the OT duration using either surgical or non-surgical approaches. With the emerging concept of "accelerated orthodontics," scientific interest has been focused on chemical and electrical stimuli in combination with mechanical forces for rapid bone turnover and more stable results.
  • Phase 1: an early, usually small safety study
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 and older

You may be able to join if

  • Patient with permanent dentition
  • Angles class 1,class II dental malocclusion, indicated for bilateral maxillary first premolar extraction
  • minimum 5 of extraction space

You likely can't join if

  • several craniofacial deformities such as cleft lip and palate
  • history of bone disease such as osteoporosis or diabetes
  • pregnant and lactating women

The study team makes the final eligibility decision.

Where it's taking place

  • Islamabad, Federal, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Islamabad, Federal, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.